Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295919
Status:
COMPLETED
Last Update Posted:
2023-04-07
First Post:
2006-02-23
Brief Title:
N2004-04 Fenretinide LXS in Treating Patients With Recurrent Refractory or Persistent Neuroblastoma
Sponsor:
Childrens Hospital Los Angeles
Organization:
Childrens Hospital Los Angeles
Organization Data
Organization:
Childrens Hospital Los Angeles
Class:
OTHER
Study ID:
CDR0000459787
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Hospital Los Angeles
Lead Sponsor Class:
OTHER
Responsible Party:
Nant Operations Center
Responsible Party Title:
NANT Consortium
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Childrens Hospital Los Angeles
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |